Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
2500 Faber Place
Palo Alto , CA 94303
May 02, 2017
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referral
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
April 16, 2015
Molecular Diagnostic Surveillance Increases Accuracy of Identification of Rejection in Heart Transplant Recipients
CareDx Inc., a molecular diagnostics company focused on the development and commercialization of clinically...
October 21, 2014
Study Demonstrates Benefits of Corus CAD Gene Expression Test Use for African American Patients
CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the...
February 07, 2014
Corus CAD Gene Expression Test Correlates With Plaque Burden, Obstructive Coronary Artery Disease
CardioDx Inc. is a molecular
October 11, 2013
New Data Shows Corus CAD Reduces Unnecessary Cardiac Testing
CardioDx Inc. announced results of two
August 09, 2012
CardioDx Announces Medicare Coverage for Corus CAD Gene Expression Test
August 9, 2012 — CardioDx Inc. announced that Palmetto GBA, a national contractor that administers Medicare benefits,...
December 14, 2011
Blood-Based Gene Expression Test Beats MPI for Ruling Out Obstructive CAD
December 14, 2011 — The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene...
December 01, 2009
Studies Examine Treatment of Acute Decompensated Heart Failure
November 18, 2009 — Results of preclinical studies with CXL-1020 demonstrate beneficial effects across the board on the...
August 31, 2009
CardioDx Completes Study of Genetic Test for Coronary Artery Disease
September 1, 2009 – CardioDx said last week it successfully completed its multicenter validation study for Corus CAD,...
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions